Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing.
about
Cancer Cell Fusion: Mechanisms Slowly UnravelThe implications of heterogeneous DNA methylation for the accurate quantification of methylationClonal evolution in cancerThe causes and consequences of genetic heterogeneity in cancer evolutionBisulfite Patch PCR enables multiplexed sequencing of promoter methylation across cancer samples.Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies.Systematic cross-validation of 454 sequencing and pyrosequencing for the exact quantification of DNA methylation patterns with single CpG resolutionAnalysis of DNA methylation in a three-generation family reveals widespread genetic influence on epigenetic regulation.Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research.Pair-barcode high-throughput sequencing for large-scale multiplexed sample analysis.Making sense of intratumor genetic heterogeneity: altered frequency of androgen receptor CAG repeat length variants in breast cancer tissues.Epigenomic evolution in diffuse large B-cell lymphomasA survey of the approaches for identifying differential methylation using bisulfite sequencing data.DREAMing: a simple and ultrasensitive method for assessing intratumor epigenetic heterogeneity directly from liquid biopsies.Multivariate analysis of a 3D mass spectral image for examining tissue heterogeneity.Intratumoral Heterogeneity of the Epigenome.Epigenetic Loss of MLH1 Expression in Normal Human Hematopoietic Stem Cell Clones is Defined by the Promoter CpG Methylation Pattern Observed by High-Throughput Methylation Specific SequencingCharacterizing natural variation using next-generation sequencing technologies.Role of epigenomics in ovarian and endometrial cancers.Endometrial tumour BRAF mutations and MLH1 promoter methylation as predictors of germline mismatch repair gene mutation status: a literature review.Epigenetics, plasticity, and evolution: How do we link epigenetic change to phenotype?Using nanobiotechnology to increase the prevalence of epigenotyping assays in precision medicine.Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer.Single copy-sensitive electrochemical assay for circulating methylated DNA in clinical samples with ultrahigh specificity based on a sequential discrimination-amplification strategy.Clonal intratumor heterogeneity of promoter hypermethylation in breast cancer by MS-MLPA.Intratumor and Intertumor Heterogeneity in Melanoma.The diagnostic role of DNA methylation in sporadic endometrial cancer: a systematic review and meta-analysis.Immunohistochemical staining for p16 and BRAFV600E is useful to distinguish between sporadic and hereditary (Lynch syndrome-related) microsatellite instable colorectal carcinomas.
P2860
Q28076643-9DD55F1A-1A6D-4739-B2B1-3D7493E551D9Q28254096-F0389400-06E8-4489-BF82-1152203BCBC0Q29547696-B7E18AEA-BAA0-4AE8-8B7B-44020DB32FA7Q29615848-F51E6A68-9D6A-4F63-BF6F-3F251110A1FAQ33632003-C286AB35-C969-4191-9EBA-B1C8BFFE5841Q33645217-2163D700-EC66-4CF7-BE66-ED018BE6C58CQ33793560-A3232DD8-1B15-4A5B-A791-375A80392BFCQ33996649-DC025032-FB74-4079-BF0C-81C55205A76EQ34085685-A5EAEE62-8156-4232-ACCF-799E053BE974Q34140859-C4DDFF36-0CAC-4614-8B98-B20747F0CD5EQ34573232-3870140B-6E1F-481B-B13E-3AC83237670DQ35543203-EBF51B33-F0EE-4859-848B-A4238405386DQ36320339-B29F23F9-BE31-4915-97C8-3E4FC25C6354Q36370872-B4D52ABF-2EED-4109-B75A-55A03D3F3CEAQ36391280-35C89BFC-9B66-4C00-B1CC-F59FDC93960DQ36854908-0D8190EC-A398-492C-A6F0-B617104034EBQ37200574-2A28C565-EC95-43AD-B61B-249163E43431Q37607823-6FE3DB4D-CBF6-4330-B6A9-96580FAF2491Q37961734-E7C90CE9-4EDF-4C3F-9F5F-96C650922782Q38123671-510743FB-F230-426E-80CF-A1D284AF7FAEQ38203488-EA5405F2-B065-4684-A6CE-6D973988D135Q38820366-AF469AFB-83CB-4443-9033-79F7090B55EEQ39017596-B602160E-D08C-4711-9643-57705551D2C8Q41671038-87B4070F-63C8-4985-B92C-1CCF4C9292C2Q45853348-BF5A3CF8-88A7-4EF0-8CC2-87C34EEB2161Q46742817-835FF160-C57A-471E-AE95-BA148AAB2340Q50350380-1B7DC02E-B278-476C-93AF-82B9C1F9A016Q54193016-148AB438-5BD3-4896-BF76-3814C0DC3781
P2860
Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intra-tumor heterogeneity of M ...... molecule bisulfite sequencing.
@en
Intra-tumor heterogeneity of M ...... molecule bisulfite sequencing.
@nl
type
label
Intra-tumor heterogeneity of M ...... molecule bisulfite sequencing.
@en
Intra-tumor heterogeneity of M ...... molecule bisulfite sequencing.
@nl
prefLabel
Intra-tumor heterogeneity of M ...... molecule bisulfite sequencing.
@en
Intra-tumor heterogeneity of M ...... molecule bisulfite sequencing.
@nl
P2093
P2860
P356
P1476
Intra-tumor heterogeneity of M ...... molecule bisulfite sequencing.
@en
P2093
David G Mutch
Katherine E Varley
Paul J Goodfellow
Robi D Mitra
Tina B Edmonston
P2860
P304
P356
10.1093/NAR/GKP457
P407
P577
2009-06-03T00:00:00Z